(Date:1/7/2009)...ical ceramic company strengthens global team , ,... a subsidiary of the largest manufacturer of techn...at Dr. Steven Hughes has joined the company as Sal... , Steven will spearhead the business developmen...erks in Europe and Latin America in addition to su...
(Date:1/7/2009)...TLETON, Colo., Jan. 7 Zuma,s Rescu...month wait, and three years of being self funded, ...nations and sponsorship! , , Zuma,s Rescue Ran...ing a non-profit charity we have been working with...o cover Equine Assisted Psychotherapy for foster c...
(Date:1/7/2009)...ochelle, NY, January 6, 2009Dedicated to the memor...man, who pioneered the fields of angiogenesis and ...blood supply and neoplastic disease, the newly rel...of Lymphatic Research and Biology includes a ser...one of the pre-eminent physician-scientists of his...
(Date:1/7/2009)...BIA, Mo. There is no cure for spinal muscular atr...kening of muscles and is the leading genetic cause...rchers have discovered a new therapeutic target th...aused by SMA. The new therapy enhanced muscle stre...e lifespan in a SMA model. , "This therapy doe...
Breaking Medicine News(10 mins):Health News:Dr. Steven Hughes Joins Medical Ceramics Provider: C5 Medical Werks 2Health News:Festschrift Issue honoring Judah Folkman, M.D., in Lymphatic Research and Biology 2Health News:Researchers discover target that could ease spinal muscular atrophy symptoms 2...h as it induces lot of alterations in the metaboli...s the risk of colorectal tumours, while drinking i.... // The study was conducted by Joseph C. Anders...Stony Brook University, Stony Brook, New York. 2,...
...e of Tropical Medicine has published the results o... said that the HIV virus has become less pathogeni...more sensitive to anti-retroviral drugs compared t...ch team compared the HIV samples collected in betw...
...ps to provide protection against lung cancer, acco...e believed to be responsible are plant-derived com...ts, grains, carrots, spinach, broccoli and other f...e University of Texas M.D. Anderson Cancer Center ...
...s lies at hand but that is the place no one looks....A weight control protein with a key role in the br...d new approaches for treating obesity and type 2 d... suggest that particular variants of the protein S...
Other Medicine News:Health News:Alcohol Consumption A Threat To Colorectal Tumours 2Health News:An Answer To Obesity: Weight Control Protein 2(Date:1/7/2009)...ucts in Development Based On Osteotech,s Proprieta...BioRegeneration; FDA Filing Anticipated in Third Q...swire-FirstCall/ -- Osteotech, Inc. (Nasdaq: O...products for regenerative healing, announced today...r its DuraTech(TM) BioRegeneration Matrix. The fir...
(Date:1/6/2009)...f AHCC for maintaining a healthy immune system , ...tly published study in Nutrition and Cancer (60(...ersity in Osaka, Japan has shown that AHCC (Active...ion by increasing the number of dendritic cells (D...nsible for presenting foreign substances to other ...
(Date:1/6/2009).... 6 Cequent Pharmaceuticals, a pio...er RNAi-based treatments to prevent and treat huma... completed a successful toxicology study of its ca...erapeutic targeting the primary oncogene (beta-cat...is). FAP is an inherited gastrointestinal disease ...
(Date:1/5/2009)...n. 5 Micromet, Inc.,(Na...ping novel, proprietary,antibodies for the treatm...s,provides an outlook on key events anticipated ...provide an update on its research and development,...il 12 to 16, 2009: Update on several preclinical B...
Breaking Medicine Technology:Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5Outlook improves for patients with non Hodgkin lymphoma over past decade 13952 1Outlook improves for patients with non Hodgkin lymphoma over past decade 13952 2Lynchburg VA Dermatologist Janet G Hickman MD Honored With Rose Hirschler Award from Womens Dermatologic Society 13949 1Lynchburg VA Dermatologist Janet G Hickman MD Honored With Rose Hirschler Award from Womens Dermatologic Society 13949 2Suzanne M Connolly MD Named 2008 2009 President of Womens Dermatologic Society 13945 1Suzanne M Connolly MD Named 2008 2009 President of Womens Dermatologic Society 13945 2Are existing large scale simulations of water dynamics wrong 3F 2450 1Are existing large scale simulations of water dynamics wrong 3F 2450 2...27, 2007 –,Merck Serono S.A. (virt-x: SEO) a... NWRN) announced today that Professor,Fabrizio Sto...st,Phase III trial of safinamide as an adjunctive ...nson’s disease (PD),patients at the American...ld in Boston from 28 April to 5 May 2007. , The ab...
...-Apr 30, 2007 - Insmed Inc.,(Nasdaq:INSM) today a...ator-sponsored clinical study of the company,s dru... HIV-associated,Adipose Redistribution Syndrome (H...onducted at the,University of California, San Fran...PLEX treatment in seven patients increased IGF-I,l...
Other Medicine Technology:Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 2Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 3Merck Serono Announces Presentation of Phase III Clinical Data on,Safinamide in Parkinson’s Disease at the American Academy of,Neurology 59th Annual Meeting 4Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 3Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 4...to / MVR knife. 1.1 mm (19G) with a 1.38 mm width ...ca). State-of-the-art manufacturing and quality co...d precise. Sure grip handles have a ridge indicati... fluid tight incision for self-sealing wounds. Gau...
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro
Renu Multiplus preservative free lubricating and rewetting drops soothe and moisturize your eyes while you're wearing soft contact lenses. The gentle preservative free formula is ideal for eyes that
Medicine Products: